Produkty 1625-11-2

CAS 1625-11-2 występuje w naszej ofercie pod nazwami: Methylprednisolone Acetate EP Impurity G, Methylprednisolone Impurity 25, 6alpha-Methyl Hydrocortisone 21-Acetate, >95% (HPLC), 6a-Methyl Hydrocortisone 21-Acetate, >95% (HPLC), 6a-Methyl hydrocortisone 21-acetate. Oferty producentów: Chemat Brand, Hubei YoungXin, TRC, Biosynth, Roth. Dostępne opakowania: on request, 10mg, 25mg, 50mg, 100mg, 200mg, 250mg.

Methylprednisolone Acetate EP Impurity G
Chemat Brand
  • opakowanie: on request
  • Warianty: 1
Zobacz produkt
Methylprednisolone Impurity 25
Hubei YoungXin
  • opakowanie: 10mg, 25mg, 50mg, 100mg
  • Warianty: 5
Zobacz produkt
6alpha-Methyl Hydrocortisone 21-Acetate, >95% (HPLC)
TRC
  • opakowanie: 100mg
  • Warianty: 1
Zobacz produkt
6a-Methyl Hydrocortisone 21-Acetate, >95% (HPLC)
TRC
  • opakowanie: 250mg, 50mg
  • Warianty: 2
Zobacz produkt
6a-Methyl hydrocortisone 21-acetate
Biosynth
  • opakowanie: 25mg, 10mg, 50mg, 100mg
  • Warianty: 5
Zobacz produkt
6a-Methyl hydrocortisone 21-acetate, min. 95 %, 10 mg
Roth
  • opakowanie: 10mg
  • Warianty: 1
od 1014,72
Zobacz produkt
6a-Methyl hydrocortisone 21-acetate, min. 95 %, 25 mg
Roth
  • opakowanie: 25mg
  • Warianty: 1
od 1581,07
Zobacz produkt
6a-Methyl hydrocortisone 21-acetate, min. 95 %, 50 mg
Roth
  • opakowanie: 50mg
  • Warianty: 1
od 2524,99
Zobacz produkt
2-((6S,8S,9S,10R,11S,13S,14S,17R)-11,17-Dihydroxy-6,10,13-trimethyl-3-oxo-2,3,6,7,8,9,10,11,12,13,14,15,16,17-tetradecahydro-1H-cyclopenta[a]phenanthren-17-yl)-2-oxoethyl acetate, Methylprednisolone Acetate Impurity, 98%
Fluorochem
  • opakowanie: 100mg
  • Warianty: 1
od 1669,22
Zobacz produkt
Wzór strukturalny: {0} (CAS {1})

[2-[(6S,8S,9S,10R,11S,13S,14S,17R)-11,17-dihydroxy-6,10,13-trimethyl-3-oxo-2,6,7,8,9,11,12,14,15,16-decahydro-1H-cyclopenta[a]phenanthren-17-yl]-2-oxoethyl] acetate (CAS 1625-11-2) to związek chemiczny o wzorze sumarycznym C24H34O6 i masie molowej 418.5 g/mol. Nazwa systematyczna IUPAC: [2-[(6S,8S,9S,10R,11S,13S,14S,17R)-11,17-dihydroxy-6,10,13-trimethyl-3-oxo-2,6,7,8,9,11,12,14,15,16-decahydro-1H-cyclopenta[a]phenanthren-17-yl]-2-oxoethyl] acetate. InChIKey: ZWEFPCOQVDIOJD-LFYFAGGJSA-N.

Dane identyfikacyjne
Wzór sumarycznyC24H34O6
Masa molowa418.5 g/mol
Nazwa IUPAC[2-[(6S,8S,9S,10R,11S,13S,14S,17R)-11,17-dihydroxy-6,10,13-trimethyl-3-oxo-2,6,7,8,9,11,12,14,15,16-decahydro-1H-cyclopenta[a]phenanthren-17-yl]-2-oxoethyl] acetate
InChIKeyZWEFPCOQVDIOJD-LFYFAGGJSA-N
SMILESC[C@H]1C[C@H]2[C@@H]3CC[C@@]([C@]3(C[C@@H]([C@@H]2[C@@]4(C1=CC(=O)CC4)C)O)C)(C(=O)COC(=O)C)O

Dane obliczone przez PubChem (NCBI)

Synonimy: 21-Acetoxy-11beta,17-dihydroxy-6alpha-methylpregn-4-ene-3,20-dione, 17-Hydroxy-6alpha-methylcorticosterone 21-acetate, 6alpha-Methylhydrocortisone 21-acetate, Methylprednisolone acetate impurity G [EP], Corticosterone, 17-hydroxy-6alpha-methyl-, 21-acetate, Pregn-4-ene-3,20-dione, 11beta,17,21-trihydroxy-6alpha-methyl-, 21-acetate, Pregn-4-ene-3,20-dione, 11.beta.,17,21-trihydroxy-6.alpha.-methyl-, 21-acetate, METHYLPREDNISOLONE ACETATE IMPURITY G [EP IMPURITY], 11beta,17-dihydroxy-6alpha-methyl-3,20-dioxopregn-4-en-21-yl acetate, METHYLPREDNISOLONE ACETATE IMPURITY G (EP IMPURITY)
Powiązane formy tego związku
[2-[(6R,8S,9S,10R,11S,13S,14S,17R)-11,17-dihydroxy-6,10,13-trimethyl-3-oxo-2,6,7,8,9,11,12,14,15,16-decahydro-1H-cyclopenta[a]phenanthren-17-yl]-2-oxoethyl] acetate C24H34O6
Izomery (ten sam wzór sumaryczny)
4-[(2S,3S)-3-[(3,4-dimethoxyphenyl)methyl]-4-methoxy-2-(methoxymethyl)butyl]-1,2-dimethoxybenzene C24H34O6
[2-[(8S,9S,10R,11S,13S,14S,17R)-11,17-dihydroxy-10,13-dimethyl-3-oxo-2,6,7,8,9,11,12,14,15,16-decahydro-1H-cyclopenta[a]phenanthren-17-yl]-2-oxoethyl] propanoate C24H34O6
[(8S,9S,10R,11S,13S,14S,17R)-11-hydroxy-17-(2-hydroxyacetyl)-10,13-dimethyl-3-oxo-2,6,7,8,9,11,12,14,15,16-decahydro-1H-cyclopenta[a]phenanthren-17-yl] propanoate C24H34O6
(1S,2S,4R,8S,9S,11S,12S,13R)-11-hydroxy-8-(2-hydroxyacetyl)-6,6,9,13-tetramethyl-5,7-dioxapentacyclo[10.8.0.02,9.04,8.013,18]icos-17-en-16-one C24H34O6
[(2R)-2-[(6S,8S,9S,10R,11S,13S,14S,17R)-11,17-dihydroxy-6,10,13-trimethyl-3-oxo-7,8,9,11,12,14,15,16-octahydro-6H-cyclopenta[a]phenanthren-17-yl]-2-hydroxyethyl] acetate C24H34O6
[2-[(6S,8S,9S,10R,11S,13S,14S,17R)-11,17-dihydroxy-6,10,13-trimethyl-3-oxo-7,8,9,11,12,14,15,16-octahydro-6H-cyclopenta[a]phenanthren-17-yl]-2-hydroxyethyl] acetate C24H34O6
[(2S,6S,8R,9S,10R,13S,14S,17R)-17-acetyl-2,6-dihydroxy-6,10,13-trimethyl-3-oxo-1,2,7,8,9,11,12,14,15,16-decahydrocyclopenta[a]phenanthren-17-yl] acetate C24H34O6
11,17-dihydroxy-10,13-dimethyl-17-[2-(2-oxopropoxy)acetyl]-2,6,7,8,9,11,12,14,15,16-decahydro-1H-cyclopenta[a]phenanthren-3-one C24H34O6